Langlui's Big Board and Options Plays

[I- B- N]

MBRX
Some scare tactics going on LOL

Metabasis Therapeutics: May Forced To Cease Ops If Addl Cap Raise Unsuccessful >MBRXLast update: 6/5/2009 4:32:54 PM(MORE TO FOLLOW) Dow Jones Newswires (201-938-5400)June 05, 2009 16:32 ET (20:32 GMT)
------------------------------------------------------------
SAN DIEGO, Jun 05, 2009 (BUSINESS WIRE) -- Metabasis Therapeutics, Inc. (MBRX) announced today that it received a $2 million payment from Roche in recognition of advances made on their research collaboration, which is focused on applying Metabasis' HepDirect(R) liver-targeting technology to Roche's proprietary lead nucleosides in order to develop new treatments for hepatitis C viral (HCV) infection. In addition, Metabasis announced that Roche has formally accepted MB11362 as a clinical candidate for development.